| 000 | 00985 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250515191804.0 | ||
| 264 | 0 | _c20100701 | |
| 008 | 201007s 0 0 eng d | ||
| 022 | _a1873-4286 | ||
| 024 | 7 |
_a10.2174/138161210790112674 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCrettol, Severine | |
| 245 | 0 | 0 |
_aPharmacogenetics of phase I and phase II drug metabolism. _h[electronic resource] |
| 260 |
_bCurrent pharmaceutical design _c2010 |
||
| 300 |
_a204-19 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPharmacogenetics |
| 650 | 0 | 4 | _aPharmacokinetics |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 700 | 1 | _aPetrovic, Nenad | |
| 700 | 1 | _aMurray, Michael | |
| 773 | 0 |
_tCurrent pharmaceutical design _gvol. 16 _gno. 2 _gp. 204-19 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/138161210790112674 _zAvailable from publisher's website |
| 999 |
_c19227575 _d19227575 |
||